NOT-FD-12-009: Notice of Correction to Funds Available and Award Budget for RFA-FD-12-019 Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products (U01)

Notice of Correction to Funds Available and Award Budget for RFA-FD-12-019 Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products (U01)

Notice Number: NOT-FD-12-009

Key Dates
Release Date: May 11, 2012

Related Notices
RFA-FD-12-019

Issued by
U.S. Food and Drug Administration (FDA)

Purpose

The purpose of this Notice is to correct the Funds Available and Award Budget for RFA-FD-12-019.

Now Reads:

Funds Available

The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications received. FDA/CDER intends to commit up to $150,000 in FY 2012.

It is anticipated that one (1) award will be made, not to exceed $150,000 in total costs (direct plus indirect).

Award Budget

The amount of financial assistance requested from FDA may not exceed $150,000.

Should Read:

Funds Available

The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications received. FDA/CDER intends to commit up to $300,000 in FY 2012.

It is anticipated that one (1) award will be made, not to exceed $300,000 in total costs (direct plus indirect

Award Budget

The amount of financial assistance requested from FDA may not exceed $300,000.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lisa Ko
Grants Management Specialist
U.S. Food and Drug Administration
Office of Acquisition and Grants Services
5630 Fishers Lane Room 1096
Rockville, MD 20857
TEL: 301-827-5095
FAX: 301-827-1044
EMAIL: [email protected]